Availability of Authorizations from EMA and FDA for Age-Appropriate Medicines Contained in the WHO Essential Medicines List for Children 2019

Lack of age-appropriate commercially drug products availability is a common problem in pediatric therapeutics; this population needs improved and safer drug delivery. In addition, biopharmaceutic aspects, dosage requirements, and swallowing abilities demand pediatric forms different to adult formula...

Descripción completa

Detalles Bibliográficos
Autores principales: delMoral-Sanchez, Jose-Manuel, Gonzalez-Alvarez, Isabel, Gonzalez-Alvarez, Marta, Navarro-Ruiz, Andres, Bermejo, Marival
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238124/
https://www.ncbi.nlm.nih.gov/pubmed/32244848
http://dx.doi.org/10.3390/pharmaceutics12040316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238124/
https://www.ncbi.nlm.nih.gov/pubmed/32244848
http://dx.doi.org/10.3390/pharmaceutics12040316

Ejemplares similares